HealthEquity, Inc. $HQY Shares Sold by Arrowstreet Capital Limited Partnership

Key Points

• Arrowstreet Capital cut its HealthEquity stake by 88.7% in the first quarter, selling 21,876 shares and retaining 2,781 shares valued at approximately $232,000.
• HealthEquity reported quarterly EPS of $1.24, beating estimates of $1.11, while revenue rose 7.2% year over year to $354.64 million. Insiders sold 17,905 shares worth about $1.65 million during the last quarter.
• Analyst sentiment remains favorable, with an average rating of “Moderate Buy” and a consensus price target of $110.93, compared with the stock’s reported opening price of $104.63.

Arrowstreet Capital Limited Partnership trimmed its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 88.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,781 shares of the company's stock after selling 21,876 shares during the period. Arrowstreet Capital Limited Partnership's holdings in HealthEquity were worth $232,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Acumen Wealth Advisors LLC purchased a new stake in HealthEquity in the 4th quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock worth $28,000 after purchasing an additional 293 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the fourth quarter worth $28,000. Leonteq Securities AG boosted its holdings in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock worth $32,000 after purchasing an additional 235 shares during the last quarter. Finally, Torren Management LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $40,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm's stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Trading Up 1.2%

Shares of HQY opened at $104.63 on Friday. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $106.42. The firm has a market capitalization of $8.75 billion, a P/E ratio of 39.19, a price-to-earnings-growth ratio of 1.76 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock's fifty day simple moving average is $93.37 and its 200 day simple moving average is $85.79.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business's revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. BTIG Research raised their price target on HealthEquity from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Friday, July 24th. Weiss Ratings upgraded HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a report on Friday, June 5th. Citigroup reaffirmed a "market outperform" rating on shares of HealthEquity in a research note on Monday, June 1st. Finally, KeyCorp reiterated an "overweight" rating on shares of HealthEquity in a report on Tuesday, May 26th. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.93.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source